NCT00021320View on ClinicalTrials.gov

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

January 31, 2004

Study Completion Date

April 30, 2009

Conditions
Esophageal Cancer
Interventions
DRUG

cisplatin

DRUG

fluorouracil

DRUG

paclitaxel

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

RADIATION

radiation therapy

Trial Locations (1)

19111-2497

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00021320 - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | Biotech Hunter | Biotech Hunter